益丰药房副总裁张朝旭拟减持不超2.025万股股份

北京商报12-10

北京商报讯（记者丁宁）12月10日晚间，益丰药房（603939）发布公告称，公司副总裁张朝旭因自身资金需求，拟通过集中竞价的交易方式减持公司股份最高不超过2.025万股，减持数量不超过其持有的25%。截至公告日，张朝旭持有公司股份8.1万股，占公司总股本比例0.007%，股份来源为限制性股票激励计划授予及资本公积金转增股本取得的股份，其中4.05万股为已解禁无限售流通股。文章来源：北京商报文章作者...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490888931?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-10 20:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2490888931","market":"sh","top_or_hot":-1,"title":"益丰药房副总裁张朝旭拟减持不超2.025万股股份","media":"北京商报","content":"<div>\n<p>北京商报讯（记者丁宁）12月10日晚间，益丰药房（603939）发布公告称，公司副总裁张朝旭因自身资金需求，拟通过集中竞价的交易方式减持公司股份最高不超过2.025万股，减持数量不超过其持有的25%。截至公告日，张朝旭持有公司股份8.1万股，占公司总股本比例0.007%，股份来源为限制性股票激励计划授予及资本公积金转增股本取得的股份，其中4.05万股为已解禁无限售流通股。文章来源：北京商报文章作者...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210205950a1e36c9d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>益丰药房副总裁张朝旭拟减持不超2.025万股股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n益丰药房副总裁张朝旭拟减持不超2.025万股股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-10 20:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210205950a1e36c9d&s=b><strong>北京商报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京商报讯（记者丁宁）12月10日晚间，益丰药房（603939）发布公告称，公司副总裁张朝旭因自身资金需求，拟通过集中竞价的交易方式减持公司股份最高不超过2.025万股，减持数量不超过其持有的25%。截至公告日，张朝旭持有公司股份8.1万股，占公司总股本比例0.007%，股份来源为限制性股票激励计划授予及资本公积金转增股本取得的股份，其中4.05万股为已解禁无限售流通股。文章来源：北京商报文章作者...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210205950a1e36c9d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210205950a1e36c9d&s=b","article_id":"2490888931","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210205950a1e36c9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2490888931","pubTimestamp":1733834836,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京商报讯（记者丁宁）12月10日晚间，益丰药房（603939）发布公告称，公司副总裁张朝旭因自身资金需求，拟通过集中竞价的交易方式减持公司股份最高不超过2.025万股，减持数量不超过其持有的25%。截至公告日，张朝旭持有公司股份8.1万股，占公司总股本比例0.007%，股份来源为限制性股票激励计划授予及资本公积金转增股本取得的股份，其中4.05万股为已解禁无限售流通股。文章来源：北京商报文章作者：丁宁原标题：益丰药房副总裁张朝旭拟减持不超2.025万股股份","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603939":"益丰药房","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","BK0209":"零售","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC"},"translate_title":"Zhang Zhaoxu, vice president of Yifeng Pharmacy, plans to reduce his holdings by no more than 20,250 shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603939":1},"content_text":"北京商报讯（记者丁宁）12月10日晚间，益丰药房（603939）发布公告称，公司副总裁张朝旭因自身资金需求，拟通过集中竞价的交易方式减持公司股份最高不超过2.025万股，减持数量不超过其持有的25%。截至公告日，张朝旭持有公司股份8.1万股，占公司总股本比例0.007%，股份来源为限制性股票激励计划授予及资本公积金转增股本取得的股份，其中4.05万股为已解禁无限售流通股。文章来源：北京商报文章作者：丁宁原标题：益丰药房副总裁张朝旭拟减持不超2.025万股股份","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490888931"}